GSA CAPITAL PARTNERS LLP - CADENCE PHARMACEUTICALS INC ownership

CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 100 filers reported holding CADENCE PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of CADENCE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2013$212,00023,3930.02%
Other shareholders

There were no reported owners of CADENCE PHARMACEUTICALS INC in Q4 2013.

NameSharesValueWeighting ↓
View complete list of CADENCE PHARMACEUTICALS INC shareholders